drugset / Trial / NCT01405612

Study to Examine the Effect of Ulimorelin on the Pharmacokinetics of Midazolam in Healthy Volunteers

NCT01405612

Phase 1 Completed 14 enrolled Norgine
RandomizedCrossoverOpen-labelDiagnostic

Summary

An open-label, single centre, randomised, cross-over study to examine the effect of ulimorelin on the pharmacokinetics of midazolam after repeat dose administration of ulimorelin in healthy volunteers.

Timeline

Start
2011-06
Primary completion
2011-07
Completion
2011-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Midazolam Small molecule Oral
Subject Ulimorelin Small molecule 480 ug/kg Intravenous